Pharma News
-
Tot Biopharm opens new biologics facility in Suzhou
Pharma | News | 0 Comment | 22 Jun, 2018
Chinese bio-pharmaceutical developer, manufacturer and marketer of oncology drugs Tot Biopharm recently announced that its second phase project, a monoclonal antibo...Read more
-
GNT Biotech, TPSC ink deal for anticancer drug Chidamide
Pharma | News | 0 Comment | 22 Jun, 2018
Taiwan's GNT Biotech & Medicals recently announced that it has granted exclusive sales and marketing rights of anticancer drug Chidamide to pharmaceutical distribution c...Read more
-
Nuance enters $58 M deal for non-opioid pain treatment in China
Pharma | News | 0 Comment | 21 Jun, 2018
Pacira Pharmaceuticals, Inc. and Nuance Biotech Co. Ltd have entered into an agreement with Nuance, a China based specialty pharmaceutical company, to advance the development and commercial...Read more
-
FDA allows label for Novartis' Cosentyx to include Psoriatic arthritis benefit
Pharma | News | 0 Comment | 20 Jun, 2018
Novartis announced today that the US Food and Drug Administration (FDA) approved the inclusion of new evidence that Cosentyx® (secukinumab) significantly slows the progression of joint ...Read more
-
US FDA issues warning letter to Taiwan Biotech
Pharma | News | 0 Comment | 19 Jun, 2018
The USFDA has sent a warning letter to Taiwan Biotech Company, one of the largest pharmaceutical companies in Taiwan. On May 31, the U.S. FDA sent a letter of warning to Taiwan Biotech Com...Read more
-
China approves country's first immunotherapy drug for cancer
Pharma | News | 0 Comment | 19 Jun, 2018
Bristol Myers Squibb recently announced that the China National Drug Administration (CNDA) has approved Opdivo (nivolumab injection) for the treatment of locally advanc...Read more
-
Lupin, Nichi-Iko unite to market biosimilar Etanercept in Japan
Pharma | News | 0 Comment | 18 Jun, 2018
Pharma major Lupin and Nichi-Iko announced that the two companies have entered into an agreement for the distribution, promotion and sale of Lupin’s recently-filed biosimilar Etanerce...Read more
-
Sage Therapeutics, Shionogi ink deal for MDD treatment
Pharma | News | 0 Comment | 17 Jun, 2018
US-based Sage Therapeutics, and Japan's Shionogi recently announced they have entered into a strategic collaboration for the clinical development and commercialization of SAGE217 for t...Read more
-
AbbVie, Eisai launch auto-injector drug delivery pen
Pharma | News | 0 Comment | 15 Jun, 2018
AbbVie has partnered with Eisai and its gastrointestinal diseases unit EA Pharma to introduce an auto-injection delivery pen for Humira drug. The auto-injector system is available in two va...Read more
-
TiGenix announces change in its Board of Directors
Pharma | News | 0 Comment | 14 Jun, 2018
TiGenix, an advanced biopharmaceutical company focused on exploiting the anti-inflammatory properties of allogeneic, or donor-derived, stem cells to develop novel therapies for serious medi...Read more
-
Suven Life Sciences gets patents in China and US
Pharma | News | 0 Comment | 14 Jun, 2018
Suven Life Sciences said it has obtained one product patent each from China and the US related to its 5-HT4 and 5 HT6 compounds. These patents add to the similar protections won in c...Read more
-
Pharma | News | 0 Comment | 13 Jun, 2018
Singapore- Galectin Therapeutics, the leading developer of therapeutics that target galectin proteins, announced that Harold H. Shlevin, Ph.D., currently the Company’s Chief Operating...Read more
-
Artelo, Syngene, Aptus enter into global R&D partnership
Pharma | News | 0 Comment | 13 Jun, 2018
Singapore- Artelo Biosciences, a biopharmaceutical company focused on the development of therapeutic treatments that modulate the endocannabinoid system, announced that it has entered into ...Read more
-
J&J agrees to sell LifeScan unit for $2.1B
Pharma | News | 0 Comment | 13 Jun, 2018
Singapore- The New Brunswick, NJ-based company recently reported that it has accepted Platinum Equity's $2.1 billion offer for J&J's LifeScan business. LifeScan is known to diabe...Read more
-
Pharma | News | 0 Comment | 12 Jun, 2018
Singapore – Aimmune Therapeutics, a biopharmaceutical company developing treatments for potentially life-threatening food allergies, announced the appointment of Jayson Dallas, M.D., ...Read more
-
AstraZeneca receives EU nod for lung cancer drug Tagrisso
Pharma | News | 0 Comment | 11 Jun, 2018
Global drug giant, AstraZeneca recently announced that the European Commission has granted marketing authorisation for Tagrisso (osimertinib) as monotherapy for the 1st-line treat...Read more
-
Zai Lab appoints AstraZeneca's William Liang as CCO
Pharma | News | 0 Comment | 11 Jun, 2018
Zai Lab, a Shanghai-based innovative biopharmaceutical company, recently announced that Mr William Liang has been appointed Chief Commercial Officer, reporting to Dr. Samanth...Read more
-
Translate Bio collaborates with Sanofi for vaccine development
Pharma | News | 0 Comment | 11 Jun, 2018
Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunct...Read more
